about
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study.The epidemiology of non-alcoholic fatty liver disease.Microbiota, NASH, HCC and the potential role of probiotics."Two drinks per day does not take your fatty liver away".Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: perspectives in the diagnosis of pancreatic cancer.Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical EvidencePrevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo StudyNatural history of nonalcoholic steatohepatitis-associated hepatocellular carcinomaCow's Milk Consumption and Health: A Health Professional's GuideNonalcoholic fatty liver disease burden - Switzerland 2018-2030Sex differences in the hepatic uptake of sulphobromophthalein in the rat
P50
Q38939495-E3E499F0-9F6C-4A3C-A71D-7D4E84562DADQ39067325-00FC8A9B-225F-4642-B587-036188DFD447Q46380108-F215A700-0E1E-429C-8058-93128487A54BQ48368770-F03E5A9D-4D57-4D37-BB9C-FC07B2FA9182Q50087735-F0E529AC-AFE5-4DBE-B1F1-73F36FC9A74CQ54182497-0DEC0D7A-E4E5-4D30-8B85-5C4212632FF3Q56341421-866F3C5F-3261-42CC-8EE9-6CE21933B4E7Q59803562-A984525E-5238-4FC7-87B3-A9013C3DD134Q91656763-91222A33-680E-43D0-8C6D-4CB2DB071D97Q91685930-964C96A2-AB25-4DFC-BD8A-FDB08A2F3D4EQ92043784-0BB844D8-3237-437C-BFAC-BFD769113B34Q93630671-DF6B28CC-6DF1-4A00-9594-7DCA8C399734
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stefano Bellentani
@ast
Stefano Bellentani
@en
Stefano Bellentani
@es
Stefano Bellentani
@nl
type
label
Stefano Bellentani
@ast
Stefano Bellentani
@en
Stefano Bellentani
@es
Stefano Bellentani
@nl
prefLabel
Stefano Bellentani
@ast
Stefano Bellentani
@en
Stefano Bellentani
@es
Stefano Bellentani
@nl
P106
P21
P31
P496
0000-0003-2836-8870